Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer

Table 2 Multivariate analysis of neutrophil-to-lymphocyte ratio-associated risk factors

Clinicopathological feature	HR	95%CI	P value
Gender (M/F)	1.219	0.693-2.146	0.492
Age (yr)	1.036	1.014-1.059	0.002
Tumor size	2.690	1.584-4.565	0.000
Differentiation degree	0.966	0.575-1.622	0.895
T staging	1.269	0.705-2.287	0.427
N staging	0.743	0.453-1.219	0.239
TNM staging	1.732	0.680-4.409	0.249
Platelet counting	0.999	0.996-1.002	0.395
CEA	1.001	0.998-1.003	0.630

M/F: Male/female; CEA: Carcinoembryonic antigen; HR: Hazard ratio.